FDA NDC Directory · JSON-LD · Markdown
NDC 69097-866 · HUMAN PRESCRIPTION DRUG · TABLET
| Labeler / Manufacturer | Cipla USA Inc. |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA204339 |
| Dosage form / route | TABLET · ORAL |
| Active ingredients | RIZATRIPTAN BENZOATE (10 mg/1) |
| Marketing started | 20160722 |
| Package count | 2 |
Source: openFDA. Public-domain (CC0).